Midwest Biomedical Accelerator Consortium (MBArC) LOI Information Sessions

The Midwest Biomedical Accelerator Consortium (MBArC) [medicine.missouri.edu], an NIH Research Evaluation and Commercialization Hub (REACH) [ncai.nhlbi.nih.gov], a partnership led by the NIH, the University of Missouri and the University of Kansas Medical Center, is aimed at accelerating the translation of discoveries originating from academic research into products that improve health. MBArC bridges the gap between academic research and industry by providing translational researchers with proof-of-concept funding and training to perform experiments and generate data that can attract follow-on funding from federal sources, investors and strategic partners to continue commercialization of the technology.

All technologies with the potential to directly impact human health are considered (i.e., Therapeutic, Diagnostic, Device, Tool and Software) for funding.

Join us at either of these information sessions to learn more:

1. Zoom information session 1, November 17, 3-3:45 CST: click here to register
2. Zoom information session 2, November 29, 10-10:45 CST: click here to register

See bellow for Call for LOIs (Due December 29, 2021).